The Journal of Experimental Medicine
Fluorescence In Vivo Endomicroscopy
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 12 June 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 121K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blander, J. M.
Right arrow Articles by Janeway, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blander, J. M.
Right arrow Articles by Janeway, C. A., , Jr.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/6/2065/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 12, June 19, 2000 2065-2074


Original Article

Alteration at a Single Amino Acid Residue in the T Cell Receptor {alpha} Chain Complementarity Determining Region 2 Changes the Differentiation of Naive CD4 T Cells in Response to Antigen from T Helper Cell Type 1 (Th1) to Th2

J. Magarian Blandera, Derek B. Sant'Angelob, Kim Bottomlya, and Charles A. Janeway, Jr.a
a Section of Immunobiology, Yale University School of Medicine and Howard Hughes Medical Institute, New Haven, Connecticut 06520
b Laboratory of T Cell Immunobiology, Immunology Program, Memorial Sloan-Kettering Cancer Center and Weil Graduate School of Medical Sciences of Cornell University, New York, New York 10021

Correspondence to: Charles A. Janeway, Jr., Section of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, P.O. Box 208011, New Haven, CT 06520. Tel:203-785-2793 Fax:203-737-1765 E-mail:charles.janeway{at}yale.edu.

To study whether changes in the structure of a T cell receptor (TCR) at a single peptide-contacting residue could affect T cell priming with antigenic peptide, we made transgenic mice with a point mutation in the TCR {alpha} chain of the D10.G4.1 (D10) TCR and bred them to D10 ß chain transgenic mice. The mutation consisted of a leucine to serine substitution at position 51 (L51S), which we had already established contacted the second amino acid of the peptide such that the response to the reference peptide was reduced by ~100-fold. A mutation in the reference peptide CA134–146 (CA-WT) from the arginine at peptide position 2 to glycine (R2G) restored full response to this altered TCR. When we examined in vitro priming of naive CD4 T cells, we observed that the response to doses of CA-WT that induced T helper cell type 1 (Th1) responses in naive CD4 T cells from mice transgenic for the D10 TCR gave only Th2 responses in naive CD4 T cells derived from the L51S. However, when we primed the same T cells with the R2G peptide, we observed Th1 priming in both D10 and L51S naive CD4 T cells. We conclude from these data that a mutation in the TCR at a key position that contacts major histocompatibility complex–bound peptide is associated with a shift in T cell differentiation from Th1 to Th2.

Key Words: mice, transgenic, interferon type II, interleukin 4, peptides


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS